Vincent D. Friedrich

Vincent D. Friedrich

Auto-generated profile, based on publicly available information

Vincent D. Friedrich

University of Leipzig, Institute for Medical Informatics, Statistics, and Epidemiology, Leipzig, Germany

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2024 in EBioMedicine
Verified
Journal Article
Open access
VFVincent D. Friedrich
Vincent D. Friedrich
PPPeter Pennitz
Peter Pennitz
EWEmanuel Wyler
Emanuel Wyler
JAJulia M. Adler
Julia M. Adler
DPDylan Postmus
Dylan Postmus
GNGeraldine Nouailles
Geraldine Nouailles
Background Translating fi ndings from animal models to human disease is essential for dissecting disease mechanisms, developing and testing precise therapeutic strategies. The coronavirus disease 2019 (COVID-19) pandemic has highlighted this need, particularly for models showing disease severity-dependent immune responses. Methods Single-cell transcriptomics (scRNAseq) is well poised to reveal similarities and differences between species at the molecular and cellular level with unprecedented resolution. However, computational methods enabling detailed matching are still scarce. Here, we provide a structured scRNAseq-based approach that we applied to scRNAseq from blood leukocytes originating from humans and hamsters affected with moderate or severe COVID-19. Findings Integration of data from patients with COVID-19 with two hamster models that develop moderate (Syrian hamster, Mesocricetus auratus) ) or severe (Roborovski hamster, Phodopus roborovskii) ) disease revealed that most cellular states are shared across species. A neural network-based analysis using variational autoencoders quantified fi ed the overall transcriptomic similarity across species and severity levels, showing highest similarity between neutrophils of Roborovski hamsters and patients with severe COVID-19, while Syrian hamsters better matched patients with moderate disease, particularly in classical monocytes. We further used transcriptome-wide differential expression analysis to identify which disease stages and cell types display strongest transcriptional changes. Interpretation Consistently, hamsters' ' response to COVID-19 was most similar to humans in monocytes and neutrophils. Disease-linked pathways found in all species specifically fi cally related to interferon response or inhibition of viral replication. Analysis of candidate genes and signatures supported the results. Our structured neural network-supported workflow fl ow could be applied to other diseases, allowing better identification fi cation of suitable animal models with similar pathomechanisms across species.

12 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
VFVincent D. Friedrich
Vincent D. Friedrich
KMKarola Mai
Karola Mai
THThomas P. Hofer
Thomas P. Hofer
ENElfriede Noessner
Elfriede Noessner
LBLorenzo Bonaguro
Lorenzo Bonaguro
MBMaren Büttner
Maren Büttner
Manual expert gating remains common practice for the definition of specific cell populations in the analysis of flow cytometry data. The increasing number of measured parameters per individual cell and high inter-rater variability makes manual gating inconsistent in many scenarios such as multi-center studies. Here, we propose ConvexGating, an AI tool that automatically learns gating strategies in an unbiased, fully data-driven, yet interpretable manner. ConvexGating scales efficiently with increasing parameter space, creating proficient strategies with low-contamination in the extracted population for previously known and so far unknown or ill-defined cell populations. The inferred strategies are independent of parent populations, for instance, plasmacytoid dendritic cells (pDCs) can be fully identified as CD45RA- CD123+. In addition to flow cytometry data, ConvexGating derives gating strategies for cyTOF (Cytometry by Time of Flight) and CITEseq (Cellular Indexing of Transcriptomes and Epitopes by Sequencing) data and supports optimal design of marker panels for cell sorting.

12 January 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
VFVincent D Friedrich
Vincent D Friedrich
PPPeter Pennitz
Peter Pennitz
EWEmanuel Wyler
Emanuel Wyler
JAJulia M Adler
Julia M Adler
DPDylan Postmus
Dylan Postmus
GNGeraldine Nouailles
Geraldine Nouailles
Translating findings from animal models to human disease is essential for dissecting disease mechanisms, developing and testing precise therapeutic strategies. The coronavirus disease 2019 (COVID-19) pandemic has highlighted this need, particularly for models showing disease severity-dependent immune responses. Single-cell transcriptomics (scRNAseq) is well poised to reveal similarities and differences between species at the molecular and cellular level with unprecedented resolution. However, computational methods enabling detailed matching are still scarce. Here, we provide a structured scRNAseq-based approach that we applied to scRNAseq from blood leukocytes originating from humans and hamsters affected with moderate or severe COVID-19. Integration of COVID-19 patient data with two hamster models that develop moderate (Syrian hamster, Mesocricetus auratus ) or severe (Roborovski hamster, Phodopus roborovskii ) disease revealed that most cellular states are shared across species. A neural network-based analysis using variational autoencoders quantified the overall transcriptomic similarity across species and severity levels, showing highest similarity between neutrophils of Roborovski hamsters and severe COVID-19 patients, while Syrian hamsters better matched patients with moderate disease, particularly in classical monocytes. We further used transcriptome-wide differential expression analysis to identify which disease stages and cell types display strongest transcriptional changes. Consistently, hamster’s response to COVID-19 was most similar to humans in monocytes and neutrophils. Disease-linked pathways found in all species specifically related to interferon response or inhibition of viral replication. Analysis of candidate genes and signatures supported the results. Our structured neural network-supported workflow could be applied to other diseases, allowing better identification of suitable animal models with similar pathomechanisms across species. Key Points: Neural networks can successfully match disease states between animal models and humans using single-cell data as shown for COVID-19 Moderately diseased patients best matched Syrian hamster cells; severely diseased patients best matched Roborovski hamster neutrophils

18 September 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
VFVincent D. Friedrich
Vincent D. Friedrich
KMKarola Mai
Karola Mai
THThomas P. Hofer
Thomas P. Hofer
ENElfriede Nößner
Elfriede Nößner
LBLorenzo Bonaguro
Lorenzo Bonaguro
MBMaren Büttner
Maren Büttner
Manual expert gating remains common practice for defining specific cell populations in flow cytometry data, but increasing numbers of measured parameters and high inter-rater variability limit consistency across studies. Cluster-based approaches use the full marker space to define cell populations more consistently, but their outputs cannot be directly implemented on a cell sorter. Here we develop ConvexGating, an artificial intelligence tool to address this gap by automatically learning interpretable gating strategies for sorting in an unbiased, data-driven manner, generating low-contamination strategies for both known and previously unknown cell populations, including plasmacytoid dendritic cells identified solely as CD57-CD13-CD45RA+ CD123+ cells. We show that ConvexGating derives sorting strategies for CD8+ subtypes and adipose progenitor cell populations, which we validate experimentally by single-cell sequencing of sorted cells. We also demonstrate that the method transfers effectively to Cytometry by Time of Flight and Cellular Indexing of Transcriptomes and Epitopes by Sequencing data and improves marker panel design for cell sorting.